Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Syndax downgraded to Neutral from Buy at H.C. Wainwright » 11:58
05/22/20
05/22
11:58
05/22/20
11:58
SNDX

Syndax

$15.70 /

-4.81 (-23.45%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Edward White downgraded Syndax to Neutral from Buy with a price target of $15, down from $25, after the company said last night that its Phase 3 E2112 trial evaluating entinostat for the treatment of patients with HR+ missed its overall survival primary endpoint. White said that the downgrade was due to the removal of entinostat from his valuation, though he noted that the company still has two drugs in development, notably its oral menin-mixed lineage leukemia inhibitor and its anti-CSF-1R monoclonal antibody called axatilimab that is in development for chronic graft versus host disease. The analyst added that he has now broken out axatilimab in his valuation model, and that he is "optimistic" for upcoming results in the fourth quarter.

ShowHide Related Items >><<
SNDX Syndax
$15.70 /

-4.81 (-23.45%)

SNDX Syndax
$15.70 /

-4.81 (-23.45%)

05/22/20 H.C. Wainwright
Syndax downgraded to Neutral from Buy at H.C. Wainwright
05/22/20
Fly Intel: Top five analyst upgrades
05/22/20 Citi
Syndax upgraded to Buy from Neutral at Citi
05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
SNDX Syndax
$15.70 /

-4.81 (-23.45%)

SNDX Syndax
$15.70 /

-4.81 (-23.45%)

Downgrade
Syndax downgraded to Neutral from Buy at H.C. Wainwright » 11:54
05/22/20
05/22
11:54
05/22/20
11:54
SNDX

Syndax

$15.77 /

-4.74 (-23.11%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Edward White downgraded Syndax to Neutral from Buy with a price target of $15, down from $25.

ShowHide Related Items >><<
SNDX Syndax
$15.77 /

-4.74 (-23.11%)

SNDX Syndax
$15.77 /

-4.74 (-23.11%)

05/22/20
Fly Intel: Top five analyst upgrades
05/22/20 Citi
Syndax upgraded to Buy from Neutral at Citi
05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
SNDX Syndax
$15.77 /

-4.74 (-23.11%)

SNDX Syndax
$15.77 /

-4.74 (-23.11%)

Upgrade
Fly Intel: Top five analyst upgrades » 10:13
05/22/20
05/22
10:13
05/22/20
10:13
HII

Huntington Ingalls

$180.87 /

-0.56 (-0.31%)

, MLM

Martin Marietta

$180.98 /

+2.14 (+1.20%)

, FLS

Flowserve

$25.00 /

-0.14 (-0.56%)

, SNDX

Syndax

$17.00 /

-3.51 (-17.11%)

, CVTI

Covenant Transportation

$11.15 /

+0.6 (+5.69%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Huntington Ingalls (HII) upgraded to Hold from Sell at Stifel with analyst Joseph DeNardi saying his prior Sell rating was driven by the CVN-79 construction progress and general margins concerns, and while he continues to see margin pressure from COVID-19 related inefficiencies, he believes that the stock's recent underperformance is pricing in the uncertainty. 2. Martin Marietta (MLM) upgraded to Overweight from Neutral at JPMorgan. 3. Flowserve (FLS) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Joshua Pokrzywinski saying while oil prices remain weak and he expects upstream equipment demand to be tepid "for the foreseeable future," Pokrzywinski sees potential for downstream spending to improve off its lows as states reopen and gasoline demand picks up. 4. Syndax (SNDX) upgraded to Buy from Neutral at Citi with analyst Joel Beatty saying the Phase 3 failure of entinostat for breast cancer leaves Syndax with two strong pipeline candidates. 5. Covenant Transportation (CVTI) upgraded to Overweight from Equal Weight at Stephens with analyst Jack Atkins saying the stock "is too cheap" and the company is making hard decisions on structural changes - such as culling loss making freight in its solo refrigerated operations and focusing on lowering its asset intensity - to drive better returns and profitability. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SNDX Syndax
$17.00 /

-3.51 (-17.11%)

MLM Martin Marietta
$180.98 /

+2.14 (+1.20%)

HII Huntington Ingalls
$180.87 /

-0.56 (-0.31%)

FLS Flowserve
$25.00 /

-0.14 (-0.56%)

CVTI Covenant Transportation
$11.15 /

+0.6 (+5.69%)

HII Huntington Ingalls
$180.87 /

-0.56 (-0.31%)

05/21/20 Stifel
Huntington Ingalls upgraded to Hold from Sell at Stifel
05/20/20 RBC Capital
RBC starts 'top value investment' Huntington Ingalls with Outperform
05/20/20 RBC Capital
Huntington Ingalls initiated with an Outperform at RBC Capital
05/19/20 Seaport Global
Huntington Ingalls initiated with a Neutral at Seaport Global
MLM Martin Marietta
$180.98 /

+2.14 (+1.20%)

05/22/20 JPMorgan
JPMorgan upgrades Martin Marietta with 17% upside into year-end
05/22/20 JPMorgan
Martin Marietta upgraded to Overweight from Neutral at JPMorgan
04/23/20 JPMorgan
Martin Marietta downgraded to Neutral from Overweight at JPMorgan
04/23/20 JPMorgan
Martin Marietta downgraded to Neutral from Overweight at JPMorgan
FLS Flowserve
$25.00 /

-0.14 (-0.56%)

05/22/20 Morgan Stanley
Morgan Stanley ups Flowserve to Equal Weight as downstream looks set to improve
05/22/20 Morgan Stanley
Flowserve upgraded to Equal Weight from Underweight at Morgan Stanley
04/17/20
Fly Intel: Top five analyst downgrades
04/17/20 Jefferies
Flowserve reinstated with a Hold from Buy at Jefferies
SNDX Syndax
$17.00 /

-3.51 (-17.11%)

05/22/20 Citi
Syndax upgraded to Buy from Neutral at Citi
05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
CVTI Covenant Transportation
$11.15 /

+0.6 (+5.69%)

05/22/20 Stephens
Stephens upgrades 'too cheap' Covenant Transportation amid structural changes
05/22/20 Stephens
Covenant Transportation upgraded to Overweight from Equal Weight at Stephens
05/21/20 Cowen
Covenant Transportation price target lowered to $12 from $19 at Cowen
05/20/20 Stifel
Covenant Transportation upgraded to Buy from Hold at Stifel
SNDX Syndax
$17.00 /

-3.51 (-17.11%)

MLM Martin Marietta
$180.98 /

+2.14 (+1.20%)

HII Huntington Ingalls
$180.87 /

-0.56 (-0.31%)

FLS Flowserve
$25.00 /

-0.14 (-0.56%)

CVTI Covenant Transportation
$11.15 /

+0.6 (+5.69%)

MLM Martin Marietta
$180.98 /

+2.14 (+1.20%)

HII Huntington Ingalls
$180.87 /

-0.56 (-0.31%)

FLS Flowserve
$25.00 /

-0.14 (-0.56%)

SNDX Syndax
$17.00 /

-3.51 (-17.11%)

MLM Martin Marietta
$180.98 /

+2.14 (+1.20%)

HII Huntington Ingalls
$180.87 /

-0.56 (-0.31%)

FLS Flowserve
$25.00 /

-0.14 (-0.56%)

On The Fly
Fly Intel: Pre-market Movers » 08:54
05/22/20
05/22
08:54
05/22/20
08:54
MRNA

Moderna

$67.01 /

-6.46 (-8.79%)

, DE

Deere

$142.81 /

+0.51 (+0.36%)

, PDD

Pinduoduo

$60.04 /

-0.89 (-1.46%)

, ICLK

iClick Interactive Asia

$5.41 /

+0.31 (+6.08%)

, TLGT

Teligent

$0.42 /

+0.0125 (+3.06%)

, PANW

Palo Alto Networks

$229.36 /

-4.89 (-2.09%)

, NVDA

Nvidia

$351.01 /

-7.78 (-2.17%)

, FL

Foot Locker

$29.37 /

+1.05 (+3.71%)

, INTU

Intuit

$290.30 /

-0.4 (-0.14%)

, HPE

HP Enterprise

$10.35 /

+0.07 (+0.68%)

, SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

, ROKU

Roku

$114.76 /

-2.3 (-1.96%)

, AMRN

Amarin

$7.29 /

-0.175 (-2.35%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
TLGT Teligent
$0.42 /

+0.0125 (+3.06%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROKU Roku
$114.76 /

-2.3 (-1.96%)

PDD Pinduoduo
$60.04 /

-0.89 (-1.46%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

MRNA Moderna
$67.01 /

-6.46 (-8.79%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

ICLK iClick Interactive Asia
$5.41 /

+0.31 (+6.08%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

FL Foot Locker
$29.37 /

+1.05 (+3.71%)

DE Deere
$142.81 /

+0.51 (+0.36%)

AMRN Amarin
$7.29 /

-0.175 (-2.35%)

MRNA Moderna
$67.01 /

-6.46 (-8.79%)

05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
05/19/20 BMO Capital
Moderna price target raised to $112 from $83 at BMO Capital
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
DE Deere
$142.81 /

+0.51 (+0.36%)

05/22/20 Goldman Sachs
Goldman Sachs sees Deere shares outperforming today after earnings
05/20/20 Citi
Deere price target lowered to $145 from $155 at Citi
04/20/20 OTR Global
Farm Equipment Manufacturers downgraded to Negative at OTR Global
04/20/20 Stephens
USDA aid package a positive for Large Ag, says Stephens
PDD Pinduoduo
$60.04 /

-0.89 (-1.46%)

05/22/20 CLSA
Pinduoduo price target raised to $72 from $46.50 at CLSA
05/20/20 BofA
Pinduoduo downgraded to Neutral from Buy at BofA
04/29/20 KeyBanc
Pinduoduo price target raised to $65 from $50 at KeyBanc
04/20/20 Credit Suisse
Pinduoduo upgraded to Outperform from Neutral at Credit Suisse
ICLK iClick Interactive Asia
$5.41 /

+0.31 (+6.08%)

05/22/20 Roth Capital
Roth ups iClick target to $7.50, remains buyer after Q1 report
03/31/20 Roth Capital
iClick Interactive Asia Q4 pre-announcement 'in-line,' says Roth Capital
01/27/20 Alliance Global Partners
iClick Interactive Asia initiated with a Buy at Alliance Global Partners
12/05/19 Jefferies
iClick Interactive Asia initiated with a Buy at Jefferies
TLGT Teligent
$0.42 /

+0.0125 (+3.06%)

10/03/19
Fly Intel: Top five analyst downgrades
10/03/19 Raymond James
Teligent downgraded at Raymond James following strategic review announcement
10/03/19 Raymond James
Teligent downgraded to Market Perform from Outperform at Raymond James
PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

05/22/20 BMO Capital
Palo Alto Networks price target raised to $260 from $230 at BMO Capital
05/22/20 RBC Capital
Palo Alto Networks price target raised to $248 from $225 at RBC Capital
05/22/20 Northland
Palo Alto Networks price target raised to $285 from $274 at Northland
05/22/20 Oppenheimer
Palo Alto Networks price target raised to $265 from $225 at Oppenheimer
NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

05/22/20 JPMorgan
Nvidia price target raised to $405 from $305 at JPMorgan
05/22/20 Rosenblatt
Nvidia price target raised to $400 from $340 at Rosenblatt
05/22/20 Raymond James
Nvidia price target raised to $370 from $330 at Raymond James
05/22/20 Craig-Hallum
Nvidia price target raised to $335 from $300 at Craig-Hallum
FL Foot Locker
$29.37 /

+1.05 (+3.71%)

05/20/20 Susquehanna
Foot Locker price target raised to $28 from $20 at Susquehanna
05/19/20 Pivotal Research
Foot Locker price target lowered to $37 from $45 at Pivotal Research
05/15/20 Deutsche Bank
Foot Locker price target lowered to $27 from $36 at Deutsche Bank
05/08/20 Raymond James
Foot Locker price target lowered to $30 from $50 at Raymond James
INTU Intuit
$290.30 /

-0.4 (-0.14%)

05/22/20 RBC Capital
Intuit price target raised to $315 from $280 at RBC Capital
05/22/20 Guggenheim
Guggenheim ups Intuit price target to $320 with odds of worst case diminishing
05/22/20 Citi
Intuit price target raised to $292 from $272 at Citi
05/22/20 Wells Fargo
Intuit price target raised to $330 from $310 at Wells Fargo
HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Raymond James
HP Enterprise downgraded to Market Perform from Outperform at Raymond James
05/22/20 Morgan Stanley
Second quarter 'not yet a bottom' for HP Enterprise, says Morgan Stanley
05/22/20 Citi
HP Enterprise earnings call leaves more questions than answers, says Citi
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/22/20 H.C. Wainwright
Syndax downgraded to Neutral from Buy at H.C. Wainwright
05/22/20 H.C. Wainwright
Syndax downgraded to Neutral from Buy at H.C. Wainwright
05/22/20
Fly Intel: Top five analyst upgrades
05/22/20 Citi
Syndax upgraded to Buy from Neutral at Citi
ROKU Roku
$114.76 /

-2.3 (-1.96%)

05/22/20 Stephens
Roku downgraded to Equal Weight on worries about TCL at Stephens
05/22/20 Stephens
Roku downgraded to Equal Weight from Overweight at Stephens
05/08/20 Susquehanna
Roku price target lowered to $145 from $170 at Susquehanna
AMRN Amarin
$7.29 /

-0.175 (-2.35%)

05/22/20 Roth Capital
Roth Capital says buy Amarin as at-risk generic launch unlikely
05/22/20 Roth Capital
Roth sees low likelihood of at-risk generic launch of Vascepa
05/22/20 Roth Capital
Amarin selloff today a buying opportunity, says Roth Capital
05/22/20 Cantor Fitzgerald
Cantor Fitzgerald still positive on Amarin despite Hikma's generic approval
TLGT Teligent
$0.42 /

+0.0125 (+3.06%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROKU Roku
$114.76 /

-2.3 (-1.96%)

PDD Pinduoduo
$60.04 /

-0.89 (-1.46%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

MRNA Moderna
$67.01 /

-6.46 (-8.79%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

ICLK iClick Interactive Asia
$5.41 /

+0.31 (+6.08%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

FL Foot Locker
$29.37 /

+1.05 (+3.71%)

DE Deere
$142.81 /

+0.51 (+0.36%)

AMRN Amarin
$7.29 /

-0.175 (-2.35%)

  • 19
    May
ROKU Roku
$114.76 /

-2.3 (-1.96%)

PDD Pinduoduo
$60.04 /

-0.89 (-1.46%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

MRNA Moderna
$67.01 /

-6.46 (-8.79%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

FL Foot Locker
$29.37 /

+1.05 (+3.71%)

DE Deere
$142.81 /

+0.51 (+0.36%)

AMRN Amarin
$7.29 /

-0.175 (-2.35%)

TLGT Teligent
$0.42 /

+0.0125 (+3.06%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROKU Roku
$114.76 /

-2.3 (-1.96%)

PDD Pinduoduo
$60.04 /

-0.89 (-1.46%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

MRNA Moderna
$67.01 /

-6.46 (-8.79%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

FL Foot Locker
$29.37 /

+1.05 (+3.71%)

DE Deere
$142.81 /

+0.51 (+0.36%)

AMRN Amarin
$7.29 /

-0.175 (-2.35%)

ROKU Roku
$114.76 /

-2.3 (-1.96%)

PDD Pinduoduo
$60.04 /

-0.89 (-1.46%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

MRNA Moderna
$67.01 /

-6.46 (-8.79%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

FL Foot Locker
$29.37 /

+1.05 (+3.71%)

DE Deere
$142.81 /

+0.51 (+0.36%)

AMRN Amarin
$7.29 /

-0.175 (-2.35%)

Upgrade
Syndax upgraded to Buy from Neutral at Citi » 06:56
05/22/20
05/22
06:56
05/22/20
06:56
SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

Citi analyst Joel Beatty…

Citi analyst Joel Beatty upgraded Syndax Pharmaceuticals to Buy from Neutral with a price target of $23, down from $26. The Phase 3 failure of entinostat for breast cancer leaves Syndax with two strong pipeline candidates, Beatty tells investors in a research note. The analyst sees the stock settling around $17 per share in the near-term given the failure. However, he views SNDX-5613 and Axatilimab as "promising pipeline agents with meaningful data providing compelling early validation." Beatty sees a favorable risk/reward heading into additional Phase 2 data for both agents in Q4.

ShowHide Related Items >><<
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

Over a week ago
On The Fly
Fly Intel: After-Hours Movers » 19:01
05/21/20
05/21
19:01
05/21/20
19:01
PANW

Palo Alto Networks

$229.36 /

-4.89 (-2.09%)

, RAMP

LiveRamp

$38.70 /

-0.16 (-0.41%)

, CRMT

America's Car-Mart

$73.77 /

+2.825 (+3.98%)

, ELF

e.l.f. Beauty

$14.56 /

+0.34 (+2.39%)

, A

Agilent

$80.84 /

-0.83 (-1.02%)

, SPLK

Splunk

$163.27 /

+0.11 (+0.07%)

, DECK

Deckers Brands

$167.93 /

+5.83 (+3.60%)

, PRSP

Perspecta

$22.93 /

-0.4 (-1.71%)

, PLUS

ePlus

$76.14 /

+4.14 (+5.75%)

, NAVB

Navidea

$1.32 /

+0.06 (+4.76%)

, USFD

US Foods

$18.56 /

-0.24 (-1.28%)

, NYMT

New York Mortgage

$2.04 /

+0.105 (+5.43%)

, AGYS

Agilysys

$20.11 /

+0.79 (+4.09%)

, HPE

HP Enterprise

$10.35 /

+0.07 (+0.68%)

, LGF.A

Lionsgate

$8.61 /

+0.13 (+1.53%)

, ROST

Ross Stores

$97.01 /

+6.1 (+6.71%)

, INTU

Intuit

$290.30 /

-0.4 (-0.14%)

, CHUY

Chuy's

$16.13 /

+0.09 (+0.56%)

, NVDA

Nvidia

$351.01 /

-7.78 (-2.17%)

, SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

, GERN

Geron

$1.95 /

+0.06 (+3.17%)

, CFRX

ContraFect

$5.38 /

-0.22 (-3.93%)

, DSS

Document Security

$8.50 /

+0.22 (+2.66%)

, H

Hyatt

$53.45 /

-0.49 (-0.91%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
USFD US Foods
$18.56 /

-0.24 (-1.28%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

PLUS ePlus
$76.14 /

+4.14 (+5.75%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

NAVB Navidea
$1.32 /

+0.06 (+4.76%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

GERN Geron
$1.95 /

+0.06 (+3.17%)

ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

DSS Document Security
$8.50 /

+0.22 (+2.66%)

DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

CRMT America's Car-Mart
$73.77 /

+2.825 (+3.98%)

CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

CFRX ContraFect
$5.38 /

-0.22 (-3.93%)

AGYS Agilysys
$20.11 /

+0.79 (+4.09%)

A Agilent
$80.84 /

-0.83 (-1.02%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

05/20/20 Wells Fargo
Palo Alto Networks price target raised to $250 from $225 at Wells Fargo
05/20/20 Monness Crespi
Palo Alto Networks price target raised to $255 from $210 at Monness Crespi
05/19/20 Dougherty
Dougherty sees Palo Alto set up for rebound, upgrades to Buy
05/19/20 Dougherty
Palo Alto Networks upgraded to Buy from Neutral at Dougherty
RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

04/27/20 Needham
LiveRamp price target lowered to $57 from $70 at Needham
04/21/20 Berenberg
LiveRamp initiated with a Buy at Berenberg
03/13/20 Stephens
LiveRamp weakness creates 'real opportunity,' says Stephens
01/26/20 First Analysis
First Analysis sees continued top-line momentum in 2020 for LiveRamp
CRMT America's Car-Mart
$73.77 /

+2.825 (+3.98%)

03/27/20 Stephens
America's Car-Mart upgraded to Overweight from Equal Weight at Stephens
02/13/20 Janney Montgomery Scott
America's Car-Mart downgraded to Neutral from Buy at Janney Montgomery Scott
ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
03/18/20 DA Davidson
e.l.f. Beauty price target lowered to $12 from $24.50 at DA Davidson
02/06/20 Piper Sandler
e.l.f. Beauty price target raised to $23 from $19 at Piper Sandler
02/04/20
Fly Intel: Top five analyst upgrades
A Agilent
$80.84 /

-0.83 (-1.02%)

03/30/20 Wells Fargo
Agilent price target lowered to $82 from $100 at Wells Fargo
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/24/20 Needham
Agilent downgraded to Hold from Buy at Needham
02/19/20 Piper Sandler
Agilent price target raised to $96 from $86 at Piper Sandler
SPLK Splunk
$163.27 /

+0.11 (+0.07%)

05/14/20 Cleveland Research
Splunk estimates at risk amid enterprise weakness, says Cleveland Research
04/27/20 Needham
Splunk price target lowered to $168 from $181 at Needham
04/24/20 Cowen
Splunk downgraded to Market Perform at Cowen
04/24/20 Cowen
Splunk downgraded to Market Perform from Outperform at Cowen
DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

05/18/20 Wedbush
Deckers Brands price target raised to $155 from $145 at Wedbush
05/15/20 Pivotal Research
Deckers Brands price target lowered to $165 from $217 at Pivotal Research
05/14/20 Wells Fargo
Wells Fargo downgrades Steven Madden to Underweight on brand weakness
04/28/20 BTIG
Deckers Brands initiated with a Buy at BTIG
PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

04/02/20 Wells Fargo
Perspecta price target lowered to $18.50 from $26 at Wells Fargo
03/30/20 William Blair
Perspecta initiated with a Market Perform at William Blair
03/25/20 Wells Fargo
Good news for government contractors in COVID -19 bill, says Wells Fargo
02/25/20 Morgan Stanley
Morgan Stanley upgrades Perspecta to Equal Weight on overhang removal
PLUS ePlus
$76.14 /

+4.14 (+5.75%)

02/11/20 Berenberg
ePlus upgraded to Buy from Hold at Berenberg
02/06/20 Sidoti
ePlus upgraded to Buy after earnings at Sidoti
02/06/20 Sidoti
ePlus upgraded to Buy from Neutral at Sidoti
11/14/19 Sidoti
ePlus downgraded to Neutral from Buy at Sidoti
NAVB Navidea
$1.32 /

+0.06 (+4.76%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
USFD US Foods
$18.56 /

-0.24 (-1.28%)

05/18/20 Guggenheim
US Foods price target lowered to $30 from $50 at Guggenheim
04/27/20 Credit Suisse
US Foods price target lowered to $27 from $47 at Credit Suisse
04/23/20 BMO Capital
US Foods downgraded to Market Perform from Outperform at BMO Capital
04/06/20 JPMorgan
US Foods price target lowered to $24 from $45 at JPMorgan
NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

04/24/20 Credit Suisse
New York Mortgage upgraded to Neutral from Underperform at Credit Suisse
04/24/20 Credit Suisse
New York Mortgage upgraded to Neutral from Underperform at Credit Suisse
03/25/20 Maxim
AGNC Investment, New York Mortgage Trust cut to Hold at Maxim
03/25/20 Maxim
New York Mortgage downgraded to Hold from Buy at Maxim
AGYS Agilysys
$20.11 /

+0.79 (+4.09%)

04/16/20 BTIG
Agilysys initiated with a Neutral at BTIG
03/16/20 Craig-Hallum
Agilysys price target lowered to $27 from $40 at Craig-Hallum
01/29/20 Craig-Hallum
Agilysys price target raised to $40 from $32 at Craig-Hallum
12/03/19 Craig-Hallum
Agilysys initiated with a Buy at Craig-Hallum
HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

05/19/20 Barclays
Barclays lowers estimates in IT hardware after April survey
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
04/27/20 Loop Capital
HP Enterprise downgraded to Hold from Buy at Loop Capital
04/22/20
Fly Intel: Top five analyst initiations
LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

04/27/20 RBC Capital
Lionsgate initiated with a Sector Perform at RBC Capital
04/22/20 Deutsche Bank
Lionsgate price target lowered to $10 from $22 at Deutsche Bank
04/21/20 JPMorgan
Lionsgate price target lowered to $11 from $14 at JPMorgan
03/23/20
Lionsgate participates in a conference call with SunTrust
ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

05/19/20 Jefferies
TJX to benefit from 'biggest liquidation sale in history,' says Jefferies
05/11/20 Nomura Instinet
Ross Stores price target raised to $100 from $80 at Nomura Instinet
04/28/20 DA Davidson
Ross Stores upgraded to Buy from Neutral at DA Davidson
04/28/20 DA Davidson
Ross Stores upgraded to Buy from Neutral at DA Davidson
INTU Intuit
$290.30 /

-0.4 (-0.14%)

05/19/20 KeyBanc
Intuit price target raised to $315 from $285 at KeyBanc
05/05/20 KeyBanc
Intuit price target raised to $285 from $275 at KeyBanc
04/17/20 RBC Capital
Intuit lowered to $280 from $345 at RBC Capital
04/13/20 Jefferies
Jefferies continues to like Intuit after approval for small business lending
CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

04/23/20 BMO Capital
Chuy's upgraded to Market Perform from Underperform at BMO Capital
04/20/20 Raymond James
Chuy's price target raised to $17 from $14 at Raymond James
04/08/20 Wedbush
Chuy's price target lowered to $17 from $26 at Wedbush
04/02/20 Raymond James
Chuy's upgraded to Outperform from Market Perform at Raymond James
NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

05/21/20 Credit Suisse
Nvidia reinstated with an Outperform at Credit Suisse
05/19/20 RBC Capital
Nvidia price target raised to $385 from $350 at RBC Capital
05/19/20 Susquehanna
Nvidia price target raised to $410 from $355 at Susquehanna
05/18/20
Fly Intel: Top five analyst upgrades
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
GERN Geron
$1.95 /

+0.06 (+3.17%)

11/19/19 B. Riley FBR
B. Riley FBR resumes Geron with Buy rating, $4 price target
11/19/19 B. Riley FBR
Geron resumed with a Buy at B. Riley FBR
09/03/19 H.C. Wainwright
Geron initiated with a Buy at H.C. Wainwright
08/15/19 Cantor Fitzgerald
Geron initiated with an Overweight at Cantor Fitzgerald
CFRX ContraFect
$5.38 /

-0.22 (-3.93%)

10/02/19 Piper Sandler
Piper says design differentiates ContraFect trial from other antibiotic studies
06/11/19 Maxim
ContraFect initiated with a Buy at Maxim
DSS Document Security
$8.50 /

+0.22 (+2.66%)

10/10/19 Aegis
Document Security initiated with a Buy rating at Aegis
H Hyatt
$53.45 /

-0.49 (-0.91%)

05/08/20
Fly Intel: Top five analyst downgrades
05/08/20 Deutsche Bank
Hyatt price target lowered to $54 from $86 at Deutsche Bank
05/08/20 Macquarie
Hyatt downgraded to Neutral from Outperform at Macquarie
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
USFD US Foods
$18.56 /

-0.24 (-1.28%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

PLUS ePlus
$76.14 /

+4.14 (+5.75%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

GERN Geron
$1.95 /

+0.06 (+3.17%)

ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

DSS Document Security
$8.50 /

+0.22 (+2.66%)

DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

CRMT America's Car-Mart
$73.77 /

+2.825 (+3.98%)

CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

CFRX ContraFect
$5.38 /

-0.22 (-3.93%)

AGYS Agilysys
$20.11 /

+0.79 (+4.09%)

A Agilent
$80.84 /

-0.83 (-1.02%)

  • 22
    May
  • 22
    May
  • 22
    May
ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

A Agilent
$80.84 /

-0.83 (-1.02%)

USFD US Foods
$18.56 /

-0.24 (-1.28%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

RAMP LiveRamp
$38.70 /

-0.16 (-0.41%)

PRSP Perspecta
$22.93 /

-0.4 (-1.71%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

LGF.A Lionsgate
$8.61 /

+0.13 (+1.53%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

ELF e.l.f. Beauty
$14.56 /

+0.34 (+2.39%)

DECK Deckers Brands
$167.93 /

+5.83 (+3.60%)

CHUY Chuy's
$16.13 /

+0.09 (+0.56%)

A Agilent
$80.84 /

-0.83 (-1.02%)

SPLK Splunk
$163.27 /

+0.11 (+0.07%)

ROST Ross Stores
$97.01 /

+6.1 (+6.71%)

PANW Palo Alto Networks
$229.36 /

-4.89 (-2.09%)

NYMT New York Mortgage
$2.04 /

+0.105 (+5.43%)

NVDA Nvidia
$351.01 /

-7.78 (-2.17%)

INTU Intuit
$290.30 /

-0.4 (-0.14%)

HPE HP Enterprise
$10.35 /

+0.07 (+0.68%)

H Hyatt
$53.45 /

-0.49 (-0.91%)

A Agilent
$80.84 /

-0.83 (-1.02%)

Hot Stocks
Syndax plunges 19.5% after E2112 Phase 3 trial fails to meet primary endpoint » 17:10
05/21/20
05/21
17:10
05/21/20
17:10
SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

Shares of Syndax…

Shares of Syndax Pharmaceuticals (SNDX) dropped nearly 20% following the resumption of trade after the company said it received the final results of E2112, the Phase 3 clinical trial conducted by ECOG-ACRIN Cancer Research Group and sponsored by the National Cancer Institute, that evaluated the investigational compound entinostat, Syndax's class I HDAC inhibitor, plus exemestane in patients with advanced hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer who have progressed on a non-steroidal aromatase inhibitor. The company said the trial did not achieve the primary endpoint of demonstrating a statistically significant overall survival benefit over hormone therapy alone. The E2112 trial was designed and conducted independently by ECOG-ACRIN under the sponsorship of the NCI, which is part of the National Institutes of Health, Syndax noted. The double-blind, placebo-controlled trial randomized a total of 608 patients with HR+, HER2- advanced breast cancer to receive exemestane in combination with entinostat or placebo. The news comes two weeks after Syndax reported lower-than-expected Q1 results, with CEO Briggs Morrison saying at the time that the company expected a potential regulatory filing for entinostat in HR+ breast cancer by year end.

ShowHide Related Items >><<
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

Hot Stocks
Syndax trading resumes  17:06
05/21/20
05/21
17:06
05/21/20
17:06
SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

 
ShowHide Related Items >><<
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

Hot Stocks
Syndax says E2112 Phase 3 trial did not achieve primary endpoint » 16:36
05/21/20
05/21
16:36
05/21/20
16:36
SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

Syndax Pharmaceuticals,…

Syndax Pharmaceuticals, Inc. announced receipt of the final results of E2112, the Phase 3 clinical trial conducted by ECOG-ACRIN Cancer Research Group and sponsored by the National Cancer Institute, that evaluated the investigational compound entinostat, Syndax's class I HDAC inhibitor, plus exemestane in patients with advanced hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer who have progressed on a non-steroidal aromatase inhibitor. The trial did not achieve the primary endpoint of demonstrating a statistically significant overall survival benefit over hormone therapy alone. "We're disappointed that the combination of entinostat and exemestane did not demonstrate a survival benefit in this historically difficult-to-treat patient population," said Briggs W. Morrison, M.D., Chief Executive Officer of Syndax. "On behalf of the entire Syndax team, we extend our sincerest gratitude to all the patients, their families and the investigators who participated in this important trial, as well as our colleagues at ECOG-ACRIN and the NCI. Based on these results, we will not be filing a New Drug Application with the U.S. Food and Drug Administration for metastatic breast cancer."

ShowHide Related Items >><<
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

Hot Stocks
Syndax trading halted, news pending  16:29
05/21/20
05/21
16:29
05/21/20
16:29
SNDX

Syndax

$20.51 /

+0.34 (+1.69%)

 
ShowHide Related Items >><<
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

05/18/20 Citi
Syndax downgraded to Neutral from Buy at Citi
05/11/20 H.C. Wainwright
Syndax price target raised to $25 from $19 at H.C. Wainwright
05/08/20 Nomura Instinet
Syndax price target raised to $31 from $16 at Nomura Instinet
05/04/20 Baird
Syndax risk/reward solid following positive clinical data, says Baird
SNDX Syndax
$20.51 /

+0.34 (+1.69%)

SNDX Syndax
$20.51 /

+0.34 (+1.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.